Agitation in Alzheimer Disease

Disease State Hub

FDA Alerts

FDA Alert

FDA Approves First Treatment of Agitation in Patients With Alzheimer Dementia

05/15/2023

Jessica Ganga

Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.

05/15/2023

Research Summaries

Conference Coverage

Dextromethorphan-Bupropion Delays Relapse of Agitation Symptoms in Patients Diagnosed With Probable Alzheimer Disease

04/29/2024

Anthony Calabro, MA

Researchers evaluated the safety and efficacy of dextromethorphan-bupropion, an FDA approved treatment of major depression disorder, for Alzheimer disease-related agitation. This study was presented at the...

04/29/2024

Research Summary

Heart Rate Variability Associated With Increased Risk of Agitation Among Patients With Alzheimer Disease

04/24/2024

Anthony Calabro, MA

Researchers collected data from the Atherosclerosis Risk in Communities Study to determine whether heart rate variability was associated with agitation risk in individuals clinically diagnosed with dementia...

04/24/2024

Research Summary

Neuropsychiatric Symptoms Associated With Neuroinflammation in Patients With Alzheimer Disease

04/15/2024

Anthony Calabro, MA

Researchers set out to determine whether microglial activation, which can trigger neuroinflammation, is associated with neuropsychiatric symptoms that often accompany Alzheimer-associated dementias,...

04/15/2024

FDA Alert

FDA Approves First Treatment of Agitation in Patients With Alzheimer Dementia

05/15/2023

Jessica Ganga

Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.

05/15/2023

Alzheimer disease

Schizophrenia Drug May Also Benefit Alzheimer Patients

03/21/2018

Findings from 2 trials that compared various doses of the atypical antipsychotic brexpiprazole with placebo have indicated that the drug may have additional benefits for patients with agitation due to...

03/21/2018

April 2024

Current Issue

April 2024

Volume 64

Issue 4